Getz Pharma started the process of market evaluation of the Philippines market in 1997 and started the regulatory and product registration process by 1999 and finally started the marketing and sales operations in 2005. Today, the company is ranked by the IMS as one of the fastest growing pharmaceutical companies in the country. Getz Pharma draws on a wealth of knowledge accumulated by our group company in the Philippines, Getz Brothers Philippines, which has been engaged in marketing and distribution of pharmaceutical products, medical devices, food products and consumer goods in the Philippines since 1918.

Nearly a century of accumulated experience and a strong, well-known Getz corporate brand gives Getz Pharma’s operations an edge in this country, which we have leveraged to establish a fully functional corporate structure and rapidly expand our portfolio of brands in this market. Getz Pharma currently markets twelve brands in the Philippines, with plans to launch approximately ten new brands each year. Getz Pharma currently promotes products in the following therapeutic segments:

• Gastroenterology
• Hepatology
• Pulmonology
• Cardiology
• Diabetology
• Orthopedics and Rheumatology
• Infectious diseases

Our marketing and sales team is led by highly experienced, agile and passionate staff, who have taken the company to the 38th position of more than 400 pharmaceutical companies in the Philippines within a short span of two years. Our sales personnel are based throughout the country, fully covering urban and rural populations, supported by a strong distribution network.

In addition to sales and marketing, Getz Pharma has a complete regulatory team in the Philippines, which has strong knowledge and understanding of BFAD (Bureau of Food and Drugs) regulatory requirements. This expertise results in the submissions of high quality dossiers that enable product registrations in the shortest possible time.

We aim to continue rapid growth in the Philippines by aggressively launching new brands, entering new therapeutic segments and driving existing brands to market leadership positions. Our vision is to become one the top 25 pharmaceutical companies in the Philippines by 2010.